Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 7.53m | 25.79% |
| Gross profit | 590.96k | 70.58% |
| Net profit | 926.13k | 20.64% |
| EBITDA | 943.77k | 55.98% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €71.5m |
Number of shares | 31.89m |
52-week high/low | €3.55 - €1.70 |
Dividend yield | 0.41% |
Dividends TTM | €0.0091 |
Beta | 0.72 |
P/E ratio | 17.69 |
PEG ratio | 0.17 |
P/B ratio | 2.25 |
P/S ratio | 1.90 |
Company profile
C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
| Name | C-RAD B |
| CEO | Tomas Blomquist |
| Headquarters | Uppsala,
up Sweden |
| Website | |
| IPO | 23/07/2007 |
| Employees | 98 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Sto | CRAD-B.ST |
Frankfurt | 24C.F |
Düsseldorf | 24C.DU |
London | 0R44.L |
Stockholm | CRAD B.ST |